Chewy's Q2 earnings reveal a shift in pet owner spending habits, with a focus on essential items like food and medication over discretionary treats. While Chewy met modest expectations and raised full-year guidance, analysts note the challenging macro environment and slower growth in core segments, leading to mixed analyst ratings and price target adjustments.
Chewy reported Q2 earnings that were largely in line with expectations, but the key takeaway is the observed shift in consumer behavior: pet owners are prioritizing essential pet food and medication while cutting back on discretionary items like treats. This indicates ongoing consumer pressure, even as management suggests the macro environment has stabilized. While Chewy raised its full-year net sales guidance, analysts like Wedbush's Scott Devitt express concern that new growth opportunities aren't scaling fast enough to offset slower core growth. This presents a short-term challenge for Chewy as it navigates a more cautious consumer, but also an opportunity if it can effectively pivot its offerings or capture further market share in essentials. Traders should monitor future reports for continued trends in discretionary spending and the performance of Chewy's new initiatives.